Dublin, Feb. 25, 2021 (GLOBE NEWSWIRE) The "Molecular Diagnostics for Cancer - Markets, Strategies and Trends. Forecasts by Cancer Type, Including Companion Dx and by Country with Executive and Consultant Guides and COVID-19 Pandemic Recession Forecast Revisions. 2021 to 2025" report has been added to ResearchAndMarkets.com's offering. A market with fundamental growth factors is impacted by the COVID-19 Pandemic. Molecular Diagnostics for Cancer is positioned to directly benefit from the explosion in genomics knowledge but shifting resources to deal with the COVID emergency may interrupt growth. Learn all about it in this new report. the publisher includes a special segment, Cancer Companion Diagnostics, a new segment of the market that is reshaping the industry. And now over 130 companies are profiled. A range of dynamic trends are pushing market growth and company valuations. Working against this dynamic market are the forces of the COVID Driven Recession. The publis
Cancer Genetics Announces Closing of $10.0 Million Private Placement Priced At-the-Market
Cancer Genetics Announces Closing of $10.0 Million Private Placement Priced At-the-Market
RUTHERFORD, N.J., Feb. 01, 2021 Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced the closing of its previously announced private placement of approximately $10.0 million through the issuance of an aggregate 2,758,624 shares of its common stock and warrants to purchase up to an aggregate 2,758,624 shares of common stock, at a combined purchase price of $3.625 per share of common stock and associated warrant in a private placement priced at-the-market under Nasdaq rules.
SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
The
Global Prostate Cancer Nuclear Medicine Diagnostics Market research report released by Data Bridge Market research provides the market segmentation based on type, market size, Product launches and applications. It identifies the global adoption of the products as one of the growth factors, driven by the availability of the product. The global research report gives the brief summary of the leading players operating in the market, their product offering, key developments, investments feasibility and returns. This
Global Prostate Cancer Nuclear Medicine Diagnostics Market report which is outcome of the ultimate dedication of industry experts, has an abundance of data that can profit anybody, regardless of their business or academic interest.